SIGMA'S Amcal and Guardian branded pharmacies are celebrating the success of the first six months of their national sleep apnoea program, which has seen a significant lift in program uptake and specialist referrals.
Amcal and Guardian Retail GM Brian Tomlin said the Sigma partnership with Philips offshoot Australian Pharmacy Sleep Services (APSS) (PD 03 May 2018) had created the nation's largest sleep apnoea network.
Tomlin added that the support received from APSS, including extensive pharmacist training and additional in-store pharmacy support, had contributed greatly to the successful roll out.
"With the assistance of APSS approximately 175 stores nationwide now offer this industry-leading service, with an additional 25 set to offer the program in the coming months," Tomlin said.
"Additionally, since Aug 2018, all sleep studies from those 175 who have undertaken the program have had their sleep studies assessed by Dr Donald Lee, Sleep Physician of Nepean Lung and Sleep, who reports on behalf of APSS."
Tomlin said the pharmacies continued to act as a "trusted and experienced first point of contact" on how Australians can manage symptoms of sleep apnoea and help to get a better night's sleep.
For more information on the program see amcal.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Nov 18
